• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic value of peripheral eosinophil counts in patients with newly diagnosed multiple myeloma.

作者信息

Chen Xu, Yue Xiaoyan, Jiang Hao, Yang Qianqian, Huang Jinwen, Pan Wenjue, Zhao Xiujie, Yin Xiufeng, Wang Panpan, Hu Liangning, Guo Xiaoli, Shao Fangfei, Xiao Haowen

机构信息

Department of Hematology and Cell Therapy, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.

Department of Nephrology, Affiliated Hospital of Jiaxing University (The First Hospital of Jiaxing), Jiaxing 314001, China.

出版信息

Cancer Biol Med. 2025 May 6;22(5):481-7. doi: 10.20892/j.issn.2095-3941.2024.0448.

DOI:10.20892/j.issn.2095-3941.2024.0448
PMID:40329504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12240192/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1167/12240192/7ac0ff51e6a4/cbm-22-05-481-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1167/12240192/7ac0ff51e6a4/cbm-22-05-481-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1167/12240192/7ac0ff51e6a4/cbm-22-05-481-g001a.jpg

相似文献

1
Prognostic value of peripheral eosinophil counts in patients with newly diagnosed multiple myeloma.外周血嗜酸性粒细胞计数对新诊断多发性骨髓瘤患者的预后价值
Cancer Biol Med. 2025 May 6;22(5):481-7. doi: 10.20892/j.issn.2095-3941.2024.0448.
2
MASS-4 is more suitable than MASS-3 for prognostic stratification in transplant-eligible patients with newly diagnosed multiple myeloma.对于新诊断的适合移植的多发性骨髓瘤患者，MASS-4比MASS-3更适合用于预后分层。
Ann Med. 2025 Dec;57(1):2519671. doi: 10.1080/07853890.2025.2519671. Epub 2025 Jul 1.
3
The frequency of peripheral blood eosinophilia and its clinical significance in patients with dermatomyositis.皮肌炎患者外周血嗜酸性粒细胞增多的频率及其临床意义
GHM Open. 2025 Jun 30;5(1):37-42. doi: 10.35772/ghmo.2023.01027.
4
Oxidative Stress Score as a Simplified Surrogate for Prognostic Stratification and Therapeutic Decision-Making in Multiple Myeloma.氧化应激评分作为多发性骨髓瘤预后分层和治疗决策的简化替代指标
Pharmaceuticals (Basel). 2025 Jun 12;18(6):878. doi: 10.3390/ph18060878.
5
Isatuximab, bortezomib, lenalidomide, and limited dexamethasone in patients with transplant-ineligible multiple myeloma (REST): a multicentre, single-arm, phase 2 trial.isatuximab、硼替佐米、来那度胺与小剂量地塞米松用于不适宜移植的多发性骨髓瘤患者（REST）：一项多中心、单臂、2期试验
Lancet Haematol. 2025 Feb;12(2):e120-e127. doi: 10.1016/S2352-3026(24)00347-8.
6
Eosinophil counts predict 3-year risk of major adverse cardiovascular and cerebrovascular events in carotid artery stenosis patients.嗜酸性粒细胞计数可预测颈动脉狭窄患者发生重大心血管和脑血管不良事件的3年风险。
Sci Rep. 2025 Jul 1;15(1):20939. doi: 10.1038/s41598-025-06350-w.
7
Reduced splenic uptake of [Ga]Ga-Pentixafor following first-line chemotherapy is associated with poor prognosis in patients with newly diagnosed multiple myeloma.一线化疗后[镓]镓-喷替沙氟脾摄取降低与新诊断的多发性骨髓瘤患者预后不良相关。
EJNMMI Res. 2025 Jun 20;15(1):74. doi: 10.1186/s13550-025-01262-2.
8
Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer.循环肿瘤细胞计数与转移性激素敏感型前列腺癌患者的总生存期
JAMA Netw Open. 2024 Oct 1;7(10):e2437871. doi: 10.1001/jamanetworkopen.2024.37871.
9
Profiling the spatial architecture of multiple myeloma in human bone marrow trephine biopsy specimens with spatial transcriptomics.利用空间转录组学分析人类骨髓活检标本中多发性骨髓瘤的空间结构。
Blood. 2025 Jul 11. doi: 10.1182/blood.2025028896.
10
Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta-analysis.异常表达的长非编码 RNA 作为新诊断多发性骨髓瘤潜在的预后生物标志物：系统评价和荟萃分析。
Cancer Med. 2023 Feb;12(3):2199-2218. doi: 10.1002/cam4.5135. Epub 2022 Sep 4.

本文引用的文献

1
IL-5-producing CD4 T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer.产生 IL-5 的 CD4 T 细胞和嗜酸性粒细胞共同作用，增强乳腺癌对免疫检查点阻断的反应。
Cancer Cell. 2023 Jan 9;41(1):106-123.e10. doi: 10.1016/j.ccell.2022.11.014. Epub 2022 Dec 15.
2
Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy.肿瘤微环境中的嗜酸性粒细胞与淋巴细胞相互作用及癌症免疫治疗。
Nat Immunol. 2022 Sep;23(9):1309-1316. doi: 10.1038/s41590-022-01291-2. Epub 2022 Aug 24.
3
Human pluripotent stem cell-derived eosinophils reveal potent cytotoxicity against solid tumors.
人多能干细胞衍生的嗜酸性粒细胞对实体瘤显示出强大的细胞毒性。
Stem Cell Reports. 2021 Jul 13;16(7):1697-1704. doi: 10.1016/j.stemcr.2021.06.005. Epub 2021 Jul 1.
4
Peripheral eosinophil counts predict efficacy of anti-CD19 CAR-T cell therapy against B-lineage non-Hodgkin lymphoma.外周血嗜酸性粒细胞计数可预测抗 CD19 CAR-T 细胞疗法对 B 细胞非霍奇金淋巴瘤的疗效。
Theranostics. 2021 Mar 4;11(10):4699-4709. doi: 10.7150/thno.54546. eCollection 2021.
5
The GM-CSF-IRF5 signaling axis in eosinophils promotes antitumor immunity through activation of type 1 T cell responses.GM-CSF-IRF5 信号轴在嗜酸性粒细胞中通过激活 1 型 T 细胞应答促进抗肿瘤免疫。
J Exp Med. 2020 Dec 7;217(12). doi: 10.1084/jem.20190706.
6
A new dawn for eosinophils in the tumour microenvironment.肿瘤微环境中嗜酸性粒细胞的新曙光。
Nat Rev Cancer. 2020 Oct;20(10):594-607. doi: 10.1038/s41568-020-0283-9. Epub 2020 Jul 16.
7
Extramedullary multiple myeloma.髓外多发性骨髓瘤。
Leukemia. 2020 Jan;34(1):1-20. doi: 10.1038/s41375-019-0660-0. Epub 2019 Nov 27.
8
Extramedullary disease in multiple myeloma - controversies and future directions.多发性骨髓瘤中的髓外疾病——争议与未来方向。
Blood Rev. 2019 Jul;36:32-39. doi: 10.1016/j.blre.2019.04.002. Epub 2019 Apr 13.
9
Functions of tissue-resident eosinophils.组织驻留嗜酸性粒细胞的功能。
Nat Rev Immunol. 2017 Dec;17(12):746-760. doi: 10.1038/nri.2017.95. Epub 2017 Sep 11.
10
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.国际骨髓瘤工作组多发性骨髓瘤反应和微小残留病评估的共识标准。
Lancet Oncol. 2016 Aug;17(8):e328-e346. doi: 10.1016/S1470-2045(16)30206-6.